| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |